[Commentary on] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial Journal Article

  


Author: Robson, M.
Article Title: [Commentary on] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
Keywords: mutation; united states; incidence; breast neoplasms -- drug therapy; breast neoplasms -- familial and genetic; breast neoplasms -- prevention and control; tamoxifen -- therapeutic use; female
Journal Title: Women's Oncology Review
Volume: 2
Issue: 1
ISSN: 1473-3404
Publisher: Taylor & Francis Group  
Date Published: 2002-03-01
Start Page: 79
End Page: 80
Language: English
ACCESSION: 2004154267
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:

http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=2004154267&site=ehost-live
Notes: Accession Number: 2004154267 -- Entry Date: 20040910 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: King M, Wieand S, Hale K, Lee M, Walsh T, Owens K et al -- Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial -- JAMA 2001 Nov 14; 286(18): 2251-6, 2337-8 (research) -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20